Table 3.
Distribution of antiglaucomatous medication number
| Active principle number | Patients, n (%) | Total (%) |
|---|---|---|
| One active principle | 74 (47.7) | 74 (47.7) |
| Fixed combination | 35 (22.6) | 44 (28.4) |
| 2 separate active principles | 9 (5.8) | |
| Fixed combination + one active principle | 25 (16.1) | 30 (19.4) |
| 3 separate active principles | 5 (3.3) | |
| Fixed combination + 2 separate active principles | 6 (3.9) | 7 (4.5) |
| 4 separate active principles | 1 (0.6) | |
| Total | 155 | 155 |